How to Enhance the Bioavailability of Poorly Soluble Compounds Using Lipid-Based Formulations
We respect your privacy, by clicking ‘Watch On-Demand’ you agree to having your details passed onto the sponsors who may promote similar products and services related to your area of interest subject to their privacy policy. You have the right to object. In addition, you will receive our e-newsletter, including information on related online learning opportunities. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights, click here.
The interest in lipids formulations, and research in this area, has grown dramatically in the last 5 years. In this webcast, Dr. Jeff Browne, Ph.D of Catalent Pharma Solutions, discusses why the Interest in Lipid-Based Formulation. As well as Lipid-Based Formulation Strategies for Poorly Soluble and Hydrophobic API’s and Mechanism of Bioavailability Improvement.
Afterward, Dr. Browne discusses three case studies of:
- Lipolyzing Solution Formulation Filled into a Softgel: Cinnarizine
- Lipolyzing Suspension Formulation Filled into a Softgel: NCE
- A SEDDS Formulation Filled into a Softgel: Cyclosporin A
Presenters:
Jeff Browne
Ph.D
Catalent Pharma Solutions
We respect your privacy, by clicking ‘Watch On-Demand’ you agree to having your details passed onto the sponsors who may promote similar products and services related to your area of interest subject to their privacy policy. You have the right to object. In addition, you will receive our e-newsletter, including information on related online learning opportunities. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights, click here.
